Literature DB >> 29317774

Pancreatic cancer in 2017: Rebooting pancreatic cancer knowledge and treatment options.

Alexander Semaan1, Anirban Maitra1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29317774     DOI： 10.1038/nrgastro.2017.182

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  10 in total

Review 1.  The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications.

Authors:  Mark P Chao; Irving L Weissman; Ravindra Majeti
Journal:  Curr Opin Immunol       Date:  2012-02-04       Impact factor: 7.486

2.  Genomic analyses identify molecular subtypes of pancreatic cancer.

Authors:  Peter Bailey; David K Chang; Katia Nones; Amber L Johns; Ann-Marie Patch; Marie-Claude Gingras; David K Miller; Angelika N Christ; Tim J C Bruxner; Michael C Quinn; Craig Nourse; L Charles Murtaugh; Ivon Harliwong; Senel Idrisoglu; Suzanne Manning; Ehsan Nourbakhsh; Shivangi Wani; Lynn Fink; Oliver Holmes; Venessa Chin; Matthew J Anderson; Stephen Kazakoff; Conrad Leonard; Felicity Newell; Nick Waddell; Scott Wood; Qinying Xu; Peter J Wilson; Nicole Cloonan; Karin S Kassahn; Darrin Taylor; Kelly Quek; Alan Robertson; Lorena Pantano; Laura Mincarelli; Luis N Sanchez; Lisa Evers; Jianmin Wu; Mark Pinese; Mark J Cowley; Marc D Jones; Emily K Colvin; Adnan M Nagrial; Emily S Humphrey; Lorraine A Chantrill; Amanda Mawson; Jeremy Humphris; Angela Chou; Marina Pajic; Christopher J Scarlett; Andreia V Pinho; Marc Giry-Laterriere; Ilse Rooman; Jaswinder S Samra; James G Kench; Jessica A Lovell; Neil D Merrett; Christopher W Toon; Krishna Epari; Nam Q Nguyen; Andrew Barbour; Nikolajs Zeps; Kim Moran-Jones; Nigel B Jamieson; Janet S Graham; Fraser Duthie; Karin Oien; Jane Hair; Robert Grützmann; Anirban Maitra; Christine A Iacobuzio-Donahue; Christopher L Wolfgang; Richard A Morgan; Rita T Lawlor; Vincenzo Corbo; Claudio Bassi; Borislav Rusev; Paola Capelli; Roberto Salvia; Giampaolo Tortora; Debabrata Mukhopadhyay; Gloria M Petersen; Donna M Munzy; William E Fisher; Saadia A Karim; James R Eshleman; Ralph H Hruban; Christian Pilarsky; Jennifer P Morton; Owen J Sansom; Aldo Scarpa; Elizabeth A Musgrove; Ulla-Maja Hagbo Bailey; Oliver Hofmann; Robert L Sutherland; David A Wheeler; Anthony J Gill; Richard A Gibbs; John V Pearson; Nicola Waddell; Andrew V Biankin; Sean M Grimmond
Journal:  Nature       Date:  2016-02-24       Impact factor: 49.962

3.  Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.

Authors: 
Journal:  Cancer Cell       Date:  2017-08-14       Impact factor: 31.743

Review 4.  Pancreatic cancer.

Authors:  Jorg Kleeff; Murray Korc; Minoti Apte; Carlo La Vecchia; Colin D Johnson; Andrew V Biankin; Rachel E Neale; Margaret Tempero; David A Tuveson; Ralph H Hruban; John P Neoptolemos
Journal:  Nat Rev Dis Primers       Date:  2016-04-21       Impact factor: 52.329

5.  Covalent Guanosine Mimetic Inhibitors of G12C KRAS.

Authors:  Yuan Xiong; Jia Lu; John Hunter; Lianbo Li; David Scott; Hwan Geun Choi; Sang Min Lim; Anuj Manandhar; Sudershan Gondi; Taebo Sim; Kenneth D Westover; Nathanael S Gray
Journal:  ACS Med Chem Lett       Date:  2016-11-30       Impact factor: 4.345

6.  Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.

Authors:  John P Neoptolemos; Daniel H Palmer; Paula Ghaneh; Eftychia E Psarelli; Juan W Valle; Christopher M Halloran; Olusola Faluyi; Derek A O'Reilly; David Cunningham; Jonathan Wadsley; Suzanne Darby; Tim Meyer; Roopinder Gillmore; Alan Anthoney; Pehr Lind; Bengt Glimelius; Stephen Falk; Jakob R Izbicki; Gary William Middleton; Sebastian Cummins; Paul J Ross; Harpreet Wasan; Alec McDonald; Tom Crosby; Yuk Ting Ma; Kinnari Patel; David Sherriff; Rubin Soomal; David Borg; Sharmila Sothi; Pascal Hammel; Thilo Hackert; Richard Jackson; Markus W Büchler
Journal:  Lancet       Date:  2017-01-25       Impact factor: 79.321

Review 7.  PARP inhibitors: Synthetic lethality in the clinic.

Authors:  Christopher J Lord; Alan Ashworth
Journal:  Science       Date:  2017-03-16       Impact factor: 47.728

8.  Small RNA combination therapy for lung cancer.

Authors:  Wen Xue; James E Dahlman; Tuomas Tammela; Omar F Khan; Sabina Sood; Apeksha Dave; Wenxin Cai; Leilani M Chirino; Gillian R Yang; Roderick Bronson; Denise G Crowley; Gaurav Sahay; Avi Schroeder; Robert Langer; Daniel G Anderson; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-11       Impact factor: 11.205

9.  Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer.

Authors:  Sushrut Kamerkar; Valerie S LeBleu; Hikaru Sugimoto; Sujuan Yang; Carolina F Ruivo; Sonia A Melo; J Jack Lee; Raghu Kalluri
Journal:  Nature       Date:  2017-06-07       Impact factor: 49.962

10.  Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells.

Authors:  Cosimo Commisso; Shawn M Davidson; Rengin G Soydaner-Azeloglu; Seth J Parker; Jurre J Kamphorst; Sean Hackett; Elda Grabocka; Michel Nofal; Jeffrey A Drebin; Craig B Thompson; Joshua D Rabinowitz; Christian M Metallo; Matthew G Vander Heiden; Dafna Bar-Sagi
Journal:  Nature       Date:  2013-05-12       Impact factor: 49.962
  10 in total
  6 in total

1.  Kidney Transplantation after Extended Multivisceral Resection for Pancreatic Ductal Adenocarcinoma.

Authors:  Hryhoriy Lapshyn; Louisa Bolm; Martin Nitschke; Andreas M Luebke; Jakob R Izbicki; Yogesh K Vashist; Tobias Keck; Ulrich F Wellner
Journal:  Case Rep Transplant       Date:  2018-07-26

2.  Synthesis and mechanistic studies of quinolin-chlorobenzothioate derivatives with proteasome inhibitory activity in pancreatic cancer cell lines.

Authors:  Shuai Hu; Yi Jin; Yanghan Liu; Mats Ljungman; Nouri Neamati
Journal:  Eur J Med Chem       Date:  2018-09-15       Impact factor: 6.514

3.  Investigating a novel multiplex proteomics technology for detection of changes in serum protein concentrations that may correlate to tumor burden.

Authors:  Annie He Ren; Ioannis Prassas; Antoninus Soosaipillai; Stephanie Jarvi; Steven Gallinger; Vathany Kulasingam; Eleftherios P Diamandis
Journal:  F1000Res       Date:  2020-07-20

4.  LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer.

Authors:  Zhengwei Song; Xiaoguang Wang; Fei Chen; Qiuli Chen; Wenjun Liu; Xiaodan Yang; Xun Zhu; Xiaorong Liu; Peter Wang
Journal:  Front Oncol       Date:  2022-09-21       Impact factor: 5.738

5.  Two-photon polymerization nanofabrication of ultracompact light scattering spectroscopic probe for detection of pre-cancer in pancreatic cyst.

Authors:  Conor J Sheil; Umar Khan; Yuri N Zakharov; Mark F Coughlan; Douglas K Pleskow; Mandeep S Sawhney; Tyler M Berzin; Jonah M Cohen; Maria Glyavina; Lei Zhang; Irving Itzkan; Lev T Perelman; Le Qiu
Journal:  Opt Lasers Eng       Date:  2021-03-20       Impact factor: 5.666

6.  An Integrative Data Mining and Omics-Based Translational Model for the Identification and Validation of Oncogenic Biomarkers of Pancreatic Cancer.

Authors:  Nguyen Phuoc Long; Kyung Hee Jung; Nguyen Hoang Anh; Hong Hua Yan; Tran Diem Nghi; Seongoh Park; Sang Jun Yoon; Jung Eun Min; Hyung Min Kim; Joo Han Lim; Joon Mee Kim; Johan Lim; Sanghyuk Lee; Soon-Sun Hong; Sung Won Kwon
Journal:  Cancers (Basel)       Date:  2019-01-29       Impact factor: 6.639
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.